@ZeltaHealth
Account based inIndia
About this account
- Account based in
- India
- Connected via
- Web
Account-level information from X, not a live location or the device used for a specific post.
Making India healthier. One at a time.
Joined April 2026
- Tweets11
- Following0
- Followers514
- Likes1
This is what proactive care looks like for one person.
Imagine it built into how a company takes care of its people.
start here: zelta.in/enterprise
India has millions of people living with obesity. But this is only a surface-level issue. It starts with a few extra kilos, then higher blood sugar, cholesterol creeping up, fatty liver, hypertension.
Eventually, for many, it becomes diabetes and years of medication.
The scary part? Most people only start taking it seriously once the damage is already done.
What if we started treating metabolic health before it got to that point?
That’s why we started @ZeltaHealth
And what we’re seeing with patients goes far beyond weight loss:
8+ kg weight loss in just 3 months
Waist: 38" → 35"
Cholesterol: 272 → 140
Triglycerides: 380 → 74
HbA1c: 8.7 → 5.9%
Because the goal isn’t just to make the weight go down. It’s to improve the health markers that actually matter.
And now, we’re taking this beyond individual patients with Zelta Enterprise helping companies bring proactive metabolic healthcare to their employees.
We think it’s time to start it.
zelta.in/enterprise
Zelta retweeted
honestly the glp-1 hate is a global phenomenon.
india's version is simpler, we're just scared of needles.
which is a shame because this molecule has been around for a decade. almost every horror story you've heard is someone taking it with zero supervision. no doctor, no bloodwork, no dose adjustment, just a vial from somewhere. that's exactly what we refuse to do at zelta.
every patient here is on a doctor-led protocol, monitored every step, dose titrated to their body. and the results go beyond weight, we watch metabolic risk drop in their lab markers month after month.
don't blame the molecule for the misuse. and don't let a needle keep you from a decade of science.
The west has been having this conversation for two years now
and India is barely at the starting line - despite ~200 million people living with obesity, and almost no real infrastructure built for it.
zelta exists to close that gap.
GLP-1s might be a longevity drug.
They are also the biggest breakthrough in weight loss. I just added them to my Rx longevity platform.
Recently I went to Australia, and I experienced a huge spike in food noise. The desire to eat constantly, even when I wasn't hungry. Even when I was full.
A 7 hr time zone shift scrambled my hunger hormones.
It reminded me how debilitating food noise is. How food can become the only thing the brain thinks about, edging out everything else.
Years ago, I couldn’t stop myself from overeating every night. I was 60 lbs overweight, stressed out, and felt awful all the time.
I imagined going back in time to when I was helpless to control my eating and being presented with a drug like a GLP-1, which can flip the switch and turn down the food noise.
GLP-1s are more than weight loss, they’ve been shown in studies to:
+ lower blood pressure
+ improve blood sugar regulation
+ reduce lipid levels and inflammatory markers
We just added 6 GLP-1s for weight loss and longevity to immortals dot com.
This includes brand name meds and compounded options for personalized treatment.
Brand name:
Zepbound® (KwikPen®)
Wegovy® (injections)
Wegovy® (tablets)
Foundayo® (tablets)
Compounded options:
Personalized Tirzepatide (injections)
Personalized Semaglutide (injections)
Zelta retweeted
one of our patients came to @ZeltaHealth for weight loss.
3 months later, his HbA1c is 5.9. for the first time he can remember, he’s out of the diabetic range.
he has been living with diabetes for most of his life. this is what else changed.
Zelta retweeted
2,000 kgs.
that's how much weight our patients have lost on @ZeltaHealth so far.
super grateful for this.
one person dropped 8 kgs in a single month. only side effect we've seen is nausea, in about 5% of people. nothing major.
goal by year end - help India lose at least 20,000 kgs and get more productive, healthier, and hotter.
Zelta retweeted
some time back, i fell into a peptide rabbit hole. read everything. started experimenting. couldn't stop.
then India's semaglutide patent expired in march. 25+ generics launched overnight. suddenly one of the most powerful drugs in healthcare was accessible - but nobody had built proper infrastructure around it.
no GLP-1 specialists. no monitoring. no cold chain. 1 in 4 indian adults overweight or obese and the system just wasn't ready.
so we built @ZeltaHealth, doctor-prescribed GLP-1s with full medical oversight, delivery, follow-ups, nutrition, blood work - the whole stack.
5,000+ registered patients later, linking up with the head of BD at Novo Nordisk - the company that pioneered GLP-1s with Ozempic and Wegovy.
the peptide space in India is just getting interesting. a lot more to come.
